Chemical Formula: C18H17F3N2O3

Chemical Formula C18H17F3N2O3

Found 5 metabolite its formula value is C18H17F3N2O3

Ridogrel

5-{[(E)-{pyridin-3-yl[3-(trifluoromethyl)phenyl]methylidene}amino]oxy}pentanoic acid

C18H17F3N2O3 (366.1191208)


Ridogrel is only found in individuals that have used or taken this drug. It is a dual action drug useful for the prevention of systemic thrombo-embolism and as an adjunctive agent to thrombolytic therapy in acute myocardial infarction. However, there currently are no clinical indications for preferential use of ridogrel over aspirin.Ridogrel inhibits thromboxane A2 synthase and also blocks the thromboxane A2/prostaglandin endoperoxide receptors. Thromboxane synthetase produces thromboxane in platelets. Thromboxane is a vasoconstrictor and facilitates the clumping of platelets. Therefore by inhibiting the production and promotion of thromboxane, thrombolysis is enhanced. C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D005765 - Gastrointestinal Agents D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

   

5-[[Pyridin-3-yl-[3-(trifluoromethyl)phenyl]methylidene]amino]oxypentanoic acid

5-({[(pyridin-3-yl)[3-(trifluoromethyl)phenyl]methylidene]amino}oxy)pentanoic acid

C18H17F3N2O3 (366.1191208)


   

Ridogrel

5-{[(E)-{pyridin-3-yl[3-(trifluoromethyl)phenyl]methylidene}amino]oxy}pentanoic acid

C18H17F3N2O3 (366.1191208)


C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D005765 - Gastrointestinal Agents D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

   
   

5-[[Pyridin-3-yl-[3-(trifluoromethyl)phenyl]methylidene]amino]oxypentanoic acid

5-[[Pyridin-3-yl-[3-(trifluoromethyl)phenyl]methylidene]amino]oxypentanoic acid

C18H17F3N2O3 (366.1191208)